RxDoctor Payments Data

Brian Dahl, MD

Orthopaedic Surgery · Bismarck, NDNPI 1659500718

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Lima USA, Inc. at 56.6% of the total. Reporting peaked in 2022 at $18,474 and has fallen 98.9% since, to $209 in 2025. Among orthopaedic surgery clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,083in general payments, 2019–2025

Across 58 payments — averaging $535.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lima USA, Inc.$18K
  • Limacorporate S.p.a.$11K
  • Zimmer Biomet$982
  • Stryker$425
  • MML US, Inc.$175
  • Heron Therapeutics, Inc.$110
  • plus $503 from 14 others

What the payments were for

  • Consulting fees$10,30033%
  • Speaking & faculty fees$560%
  • Travel & lodging$18,14858%
  • Food & beverage$2,0897%
  • Education$4912%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,083 in reported general payments places this provider in the 95th percentile of 61 orthopaedic surgery providers in North Dakota.

See all orthopaedic surgery providers in North Dakota

Medicare billing

Part B allowed, 2024
$341,914
Medicare patients
575
Services billed
2,911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib106$2,273
Meloxicam187$560
Diclofenac Sodium17$525
Amoxicillin290$357
Clindamycin Hcl44$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →